RLFTY — MindMaze Therapeutics Holding SA

OTC · Health Care · Pharmaceuticals · CIK 1854078 · Switzerland
Last close
$1.73
Market Cap
$264.43M
52W High
$2.40
52W Low
$0.27
ADV30
32
Next earnings
MindMaze Therapeutics Holding SA operates as a commercial-stage biopharmaceutical and neurotechnology company in Asia, the United States, Switzerland, rest of Europe, and internationally. The company offers MindPod system, a supervised in-clinic neurorehabilitation system designed to initiate and intensify the recovery journey; MindMotion GO, which extends protocolized neurotherapeutics into outpatient and home settings; MindMotion Companion, an application that manages prescription, monitoring and documentation across MindMaze Therapeutics' neurotherapeutics ecosystem; and the patient app, a patient-facing mobile application, that supports clinic-to-home continuity by making prescribed therapy easy to follow outside the clinic. It also provides Izar hand therapy device which supports fine motor rehabilitation; Physilog sensor, a wearable inertial sensing device designed to quantify human movement; toaprun, a training for Parkinson's therapy-reimagined through play. The company was founded in 2012 and is headquartered in Geneva, Switzerland.
No quarterly fundamentals indexed for this ticker.

Annual Trend (SEC EDGAR, last 2y)

Revenues vs Net Income (last 2y)

FY endRevenuesOpIncome NetIncomeAssetsLiabilities EquityOCF
Dec 2025 642,000 -10,515,000 -9,906,000 51,530,000 13,189,000 -7,208,000
Dec 2024 0 -2,000 -1,000 93,000 7,000 -3,000

Peers — same industry

TickerNameMarket CapLastDaily %
PRLD Prelude Therapeutics Inc $265.51M $4.09
NVCT Nuvectis Pharma, Inc. $267.91M $10.10
TRDA Entrada Therapeutics, Inc. $260.10M $6.70
ALXO ALX ONCOLOGY HOLDINGS INC $259.71M $1.93
FHTX Foghorn Therapeutics Inc. $256.58M $4.37

News headlines (Yahoo Finance, 1h cache)

MindMaze Therapeutics Announces CHF 8.0 Million Strategic Equity Financing
2026-05-26 05:50 · Yahoo
MindMaze Therapeutics and Vibra Healthcare Sign Definitive Channel Partnership Agreement to Scale Advanced Neurotherapeutics Across the U.S.
2026-05-12 05:25 · Yahoo
MindMaze Therapeutics Announces Initiation of Coverage by Baader Bank
2026-03-19 06:35 · Yahoo
MindMaze Therapeutics Appoints HealthTech Veteran Zach Henderson as CEO to Accelerate Global Commercial Scale
2026-03-12 07:44 · Yahoo
MindMaze Therapeutics Provides Corporate Update and Publishes March 2026 Investor Presentation
2026-03-03 07:45 · Yahoo
MindMaze Therapeutics: Consolidating a Global Approach to Reimbursement for Next-Generation Therapeutics
2025-12-23 06:20 · Yahoo
Relief Therapeutics and NeuroX Complete Business Combination and Form MindMaze Therapeutics
2025-12-15 06:20 · Yahoo
Relief Therapeutics Shareholders Approve Business Combination with NeuroX
2025-11-14 17:40 · Yahoo
Relief Therapeutics Announces Positive Results from Pivotal Bioequivalence Study of RLF-OD032
2025-10-29 06:20 · Yahoo
Relief Therapeutics Publishes 2025 Half-Year Report
2025-08-14 05:20 · Yahoo

Recent Insider Activity

No insider activity indexed for this ticker.